AstraZeneca moves to direct US listing, keeps UK listing
AstraZeneca has laid out plans to directly list its shares in the US, as the drugmaker seeks to maximise gains from its biggest market and investor pool, even as it said that it was not exiting London.
Business
• 4 hrs
